Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name LY3009120
Trade Name
Synonyms DP-4978
Drug Descriptions

LY3009120 is a Pan-RAF inhibitor that inhibits signaling of all RAF isoforms and RAF dimers, which leads to inhibition of tumor cell growth (PMID: 26343583, PMID: 28576749).

DrugClasses RAF Inhibitor (Pan) 27
CAS Registry Number 1454682-72-4
NCIT ID C116861


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
LY3009120 LY3009120 27 1
LY3009120 + LY3214996 LY3009120 LY3214996 3 0
LY3009120 + Osimertinib LY3009120 Osimertinib 0 0
LY3009120 + Trametinib LY3009120 Trametinib 4 0
LY3009120 + Vemurafenib LY3009120 Vemurafenib 1 0

Additional content available in CKB BOOST